ArticleJournal of cellular and molecular medicine2018

Targeting c-met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma.

Yibin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.